Clinical Trials Browser

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06613516 2025-12-24

CaptAin

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT04756765 2025-08-17

Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT05488444 2024-10-22

A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT06105008 2024-08-23

Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT05212701 2024-04-30

To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms, Fatigue

NCT03841747 2024-03-12

PELICAN

Phase 2 Withdrawn

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT04102436 2024-03-12

Non-Viral TCR Gene Therapy

Phase 2 Withdrawn

BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Ovarian Neoplasms, Urogenital Neoplasms

NCT05689359 2024-03-08

Evaluation of Hydroxychloroquine to Prevent CIPN

Phase 2 Withdrawn

Breast

Breast Neoplasms, Peripheral Nervous System Diseases

NCT04199520 2024-03-04

Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT05703555 2024-02-28

INTRUSION

Phase 2 Withdrawn

BreastGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Stomach Neoplasms

NCT05315687 2024-01-19

Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line Therapy

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT04265274 2023-10-06

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT05371860 2023-09-22

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

Phase 2 Withdrawn

Breast

Pathologic Complete Response, Breast Neoplasms

NCT04901299 2023-08-01

HER2-Signal

Phase 2 Withdrawn

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT02067416 2023-02-02

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT04538833 2022-11-23

GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT05041972 2022-09-13

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

Phase 2 Withdrawn

BreastGastrointestinalThoracic

Biliary Tract Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05227131 2022-07-11

MARGARET

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT02850419 2022-04-07

EURO-DIGNITY

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT04856475 2022-03-02

NeraBrain

Phase 2 Withdrawn

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT03863301 2021-02-26

ABLATIVE-2

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT03524261 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT04220476 2020-09-21

CIMER

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT01818999 2020-08-20

Ixabepilone and SBRT For Metastatic Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT03393117 2020-07-22

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT03637868 2020-05-06

ERIBRAIN

Phase 2 Withdrawn

BreastCNS

Brain Neoplasms, Breast Neoplasms

NCT03323424 2020-01-30

IRAM

Phase 2 Withdrawn

BreastGastrointestinalHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Neoplasm Metastasis, Colorectal Neoplasms

NCT03532087 2020-01-18

PERIDENO

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT02853071 2019-11-18

BEST

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT03185871 2019-11-15

Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT02538432 2019-11-04

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

Phase 2 Withdrawn

BreastGenitourinaryThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Prostatic Neoplasms, Disease Progression

NCT03794596 2019-07-22

IMpALA

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT00960544 2019-06-14

Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT03644589 2019-04-26

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01134497 2018-05-22

PLANET

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT00615524 2018-01-12

Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms, Neoplasm Metastasis

NCT00373152 2017-12-05

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT00855114 2017-12-02

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT03032614 2017-10-10

Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients

Phase 2 Withdrawn

BreastGynecologic

Breast Neoplasms, Ovarian Neoplasms

NCT02521077 2017-06-27

Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms, Fatigue

NCT01205217 2017-06-07

ELATE

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT01227408 2017-05-02

Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT02685306 2017-03-09

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT01640847 2017-02-07

MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases

Phase 2 Withdrawn

BreastSarcomaThoracic

Adenocarcinoma, Bone Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT00450515 2016-12-06

Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00964704 2016-11-02

A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT02610621 2016-10-13

Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT02725541 2016-09-14

NATURE

Phase 2 Withdrawn

Breast

Breast Neoplasms

NCT02338531 2016-04-29

RHEA

Phase 2 Withdrawn

Breast

Breast Neoplasms

Clinical Trials

MK-5890-003

CaptAin

Talazoparib Monotherapy in PALB2 Mutation Associated Advanced Breast Cancer

A Feasibility and Acceptability Pilot Study Evaluating a Patient-Specific Targeted Intervention Using Patient Navigators or Routine Clinical Care

Study of Disitamab Vedotin With Toripalimab Verus Disitamab Vedotin in Hormone Receptor Positive, HER2-low Locally Advanced or Metastatic Breast Cancer

To Assess Efficacy and Safety of Oral Reparixin in Patients With Fatigue and Locally Advanced / Metastatic Breast Cancer

PELICAN

Non-Viral TCR Gene Therapy

Evaluation of Hydroxychloroquine to Prevent CIPN

Compare the Efficacy of Surgery Combined With Systemic Therapy and Pure Systemic Therapy in Breast Cancer Patients

INTRUSION

Radioembolization of Metastatic Breast Cancer to the Liver as a 2nd/3rd Line Therapy

Vinorelbine, Cisplatin, Disulfiram and Copper in CTC_EMT Positive Refractory Metastatic Breast Cancer.

Radiation Omission in Patients With HER2 Overexpressing Tumors With Pathologic Complete Response

HER2-Signal

PREDATOR: Neoadjuvant Gene Prediction for Breast Cancer

GM1 in the Treatment of Neurotoxicity Induced by Albumin-bound Paclitaxel

ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)

MARGARET

EURO-DIGNITY

NeraBrain

ABLATIVE-2

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

CIMER

Ixabepilone and SBRT For Metastatic Breast Cancer

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

ERIBRAIN

IRAM

PERIDENO

BEST

Celecoxib Window of Opportunity Trial to Assess Tumor and Stroma Responses

Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors

IMpALA

Correlation of Genomic Variation in Enzymes Responsible for Metabolism of Capecitabine With Drug Metabolism

Effect of Pembrolizumab and Cisplatin on Metastatic, Locally Recurrent or Inoperable Triple-Negative Breast Cancer

PLANET

Phase II Study Evaluating Exemestane Alone Or In Combination With Pazopanib In Postmenopausal Women With Hormone Receptor Positive Breast Cancer

MRI in Predicting Tumor Reponse After Radiofrequency Ablation in Women With Invasive Breast Cancer

Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

Combination of Carboplatin, Eribulin and Veliparib in Stage IV Cancer Patients

Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer

ELATE

Neoadjuvant Doxorubicin, Polyglutamate Paclitaxel, Capecitabine and Metronomic Chemotherapy in Breast Cancer

A Study of Neoadjuvant Paclitaxel in Combination With Bavituximab in Early- Stage Triple- Negative Breast Cancer

MRI Guided High Intensity Focused Ultrasound (HIFU) and ThermoDox for Palliation of Painful Bone Metastases

Vinflunine and Capecitabine in Treating Patients With Previously Treated Metastatic Breast Cancer

A Study of Herceptin (Trastuzumab) in Combination With Avastin (Bevacizumab) and Sequential Xeloda (Capecitabine) or Docetaxel in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer

Safety and Efficacy of Sentinel Node Biopsy Omission for Breast Cancer Patients Who Plan to Have Adjuvant Chemotherapy

NATURE

RHEA